The S4 System is used to promote spinal fusion of the cervical thoracic spine and accipito-cervico-thoracic junction in patients with degenerative disease or fracture, according to the release.
Read the Aesculap release on the FDA-approved S4 system.
Read more coverage on Aesculap:
– Aesculap Launches New Generation Surgical System
– Aesculap’s A-FIX Spinal System Receives FDA Clearance
– Aesculap Launches New Generation Surgical System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
